Clinical Trials List
2024-11-01 - 2027-04-30
Others
Recruiting9
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 林宗哲 無
- WEI-LI MA 無
- YEN-TING LIN 無
- 黃信端 無
- Chia-Chi Lin 無
- 黃得瑞 無
- 吳尚俊 無
- JIN-YUAN SHIH 無
- James Chih-Hsin Yang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃怡菁 無
- 鍾秉軒 無
- Shang-Yin Wu 無
- Seu-Chun Yang 無
- 黃怡璇 無
- Yu-Min Yeh 無
- Chien-Chung Lin 無
- 蔡政軒 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- JING-QUAN ZHENG Division of Thoracic Medicine
- Ching-Shan Luo Division of Thoracic Medicine
- Po-Hao Feng Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YEN-HAN TSENG 無
- Yung-Hung Luo 無
- Hsu-ching Huang 無
- Chi-Lu Chiang 無
- 廖映庭 無
- 趙恒勝 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Yen Tu 無
- Chia-Hsiang Li Division of General Internal Medicine
- 陳鴻仁 無
- Yu-Chao Lin 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 莊政皓 無
- Inn-Wen Chong 無
- 郭家佑 無
- 李玫萱 Division of Thoracic Medicine
- Chih-Jen Yang 無
- Ying-Ming Tsai Tsai 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
726 participants
